Clinical Trials Browser

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

NCT03803787 2025-05-01

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

Radiation Fibrosis Syndrome, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Radiation Pneumonitis, Lung Injury

NCT02496585 2025-04-16

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

Phase 2 Completed

34 enrolled 10 charts

Thoracic

Lung Neoplasms, Radiation Pneumonitis

NCT04636593 2021-01-12

A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC

Phase 2 Unknown

43 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiation Pneumonitis

NCT04632342 2020-11-17

Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients

Phase 2 Unknown

87 enrolled

Thoracic

Lung Neoplasms, Radiation Pneumonitis

NCT02452463 2020-04-06

Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy

Phase 2 Terminated

8 enrolled 25 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

NCT01754909 2019-10-08

Mitigation of Radiation Pneumonitis and Fibrosis

Phase 2 Completed

50 enrolled 10 charts

Thoracic

Lung Neoplasms, Radiation Pneumonitis

Clinical Trials

RESPIRE-ILD

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC

Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients

Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy

Mitigation of Radiation Pneumonitis and Fibrosis